LYEL
Price
$11.06
Change
-$0.04 (-0.36%)
Updated
Aug 29, 04:04 PM (EDT)
Capitalization
216.7M
TYRA
Price
$12.55
Change
+$0.18 (+1.46%)
Updated
Aug 29, 04:22 PM (EDT)
Capitalization
659.29M
62 days until earnings call
Interact to see
Advertisement

LYEL vs TYRA

Header iconLYEL vs TYRA Comparison
Open Charts LYEL vs TYRABanner chart's image
Lyell Immunopharma
Price$11.06
Change-$0.04 (-0.36%)
Volume$100
Capitalization216.7M
Tyra Biosciences
Price$12.55
Change+$0.18 (+1.46%)
Volume$500
Capitalization659.29M
LYEL vs TYRA Comparison Chart in %
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYEL vs. TYRA commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a Buy and TYRA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (LYEL: $11.10 vs. TYRA: $12.37)
Brand notoriety: LYEL and TYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 15% vs. TYRA: 111%
Market capitalization -- LYEL: $216.7M vs. TYRA: $659.29M
LYEL [@Biotechnology] is valued at $216.7M. TYRA’s [@Biotechnology] market capitalization is $659.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileTYRA’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • TYRA’s FA Score: 0 green, 5 red.
According to our system of comparison, TYRA is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 3 TA indicator(s) are bullish while TYRA’s TA Score has 5 bullish TA indicator(s).

  • LYEL’s TA Score: 3 bullish, 5 bearish.
  • TYRA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TYRA is a better buy in the short-term than LYEL.

Price Growth

LYEL (@Biotechnology) experienced а +4.23% price change this week, while TYRA (@Biotechnology) price change was +5.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

Reported Earning Dates

TYRA is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TYRA($659M) has a higher market cap than LYEL($217M). TYRA YTD gains are higher at: -11.007 vs. LYEL (-13.281). TYRA has higher annual earnings (EBITDA): -121.07M vs. LYEL (-199.95M). TYRA has more cash in the bank: 296M vs. LYEL (277M). TYRA has less debt than LYEL: TYRA (6.02M) vs LYEL (46.6M). LYEL has higher revenues than TYRA: LYEL (60K) vs TYRA (0).
LYELTYRALYEL / TYRA
Capitalization217M659M33%
EBITDA-199.95M-121.07M165%
Gain YTD-13.281-11.007121%
P/E RatioN/AN/A-
Revenue60K0-
Total Cash277M296M94%
Total Debt46.6M6.02M774%
TECHNICAL ANALYSIS
Technical Analysis
LYELTYRA
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 19 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GROYX62.62N/A
N/A
Victory Pioneer Select Mid Cap Growth Y
BHSRX57.12N/A
N/A
BlackRock Health Sciences Opps R
MPISX7.60N/A
N/A
BNY Mellon Income Stock M
LSVFX11.60N/A
N/A
LSV Global Managed Volatility Instl
BUITX24.06N/A
N/A
Buffalo Mid Cap Discovery Inst

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
-1.60%
VCYT - LYEL
46%
Loosely correlated
+4.68%
CRBU - LYEL
40%
Loosely correlated
-2.02%
BEAM - LYEL
39%
Loosely correlated
-0.06%
TYRA - LYEL
37%
Loosely correlated
-3.96%
ZNTL - LYEL
36%
Loosely correlated
-3.30%
More

TYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TYRA has been loosely correlated with NRIX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TYRA jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TYRA
1D Price
Change %
TYRA100%
-3.96%
NRIX - TYRA
45%
Loosely correlated
-1.47%
AURA - TYRA
44%
Loosely correlated
-0.16%
RGNX - TYRA
42%
Loosely correlated
+2.15%
DYN - TYRA
41%
Loosely correlated
+0.81%
ZNTL - TYRA
41%
Loosely correlated
-3.30%
More